News Details
03/11/2026 17:33
Dr. Reddy's Lab. - Clarification sought from Dr Reddys Laboratories Ltd
The Exchange has sought Clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.firstpost.com dated November 03, 2026 (Link : https://www.firstpost.com/business/indias-dr-reddys-gets-us-nod-for-40-generic-hiv-prevention-shot-for-120-poorer-countries-14057224.html) titled \India's Dr Reddy's gets US nod for $40 generic HIV prevention shot for 120 poorer countries\.
The Company is requested to submit its clarification to the Exchange in terms of the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015.